These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26724169)

  • 21. Endovascular Management of Refractory Hepatic Encephalopathy Complication of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Comprehensive Review and Clinical Practice Algorithm.
    Pereira K; Carrion AF; Salsamendi J; Doshi M; Baker R; Kably I
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):170-82. PubMed ID: 26285910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of hepatic encephalopathy and portal hemodynamics by Doppler ultrasonography after a transjugular intrahepatic portosystemic shunt].
    Kimura M; Sato M; Kawai N; Tanihata H; Horihata K; Shioyama Y; Sonomura T; Yoshikawa A; Kishi K; Terada M; Yamada R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Apr; 57(5):233-7. PubMed ID: 9164110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory hepatic encephalopathy due to concomitant transjugular intrahepatic portosystemic shunt and spontaneous mesocaval shunt controlled by embolization of the competitive portosystemic shunt.
    Cura M
    Clin Imaging; 2009; 33(3):231-3. PubMed ID: 19411031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatic encephalopathy after transjugular intrahepatic portosystemic stent shunt (TIPS)].
    Sauer P; Theilmann L; Stremmel W; Stiehl A
    Z Gastroenterol; 1995 May; 33(5):277-8. PubMed ID: 7610697
    [No Abstract]   [Full Text] [Related]  

  • 27. [TIPS--transjugular intrahepatic portosystemic shunt. Experiences from a recently started center].
    Astrup LB; Grønbaek H; Redsted S; Nielsen DT; Vilstrup H
    Ugeskr Laeger; 2003 Jan; 165(5):443-6. PubMed ID: 12599839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of transjugular intrahepatic portosystemic shunt (TIPS)-induced hepatic encephalopathy using a strictured self-expanding covered stent.
    Cox MW; Lin PH; Bush RL; Lumsden AB
    Cardiovasc Intervent Radiol; 2003; 26(6):539-42. PubMed ID: 15061178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary creation of an externally constrained TIPS: a technique to control reduction of the portosystemic gradient.
    Farsad K; Kolbeck KJ; Keller FS; Barton RE; Kaufman JA
    AJR Am J Roentgenol; 2015 Apr; 204(4):868-71. PubMed ID: 25794080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children.
    Di Giorgio A; Agazzi R; Alberti D; Colledan M; D'Antiga L
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):594-600. PubMed ID: 22228077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transjugular placement of an intrahepatic portosystemic shunt as current treatment for complications of portal hypertension].
    Buiskool RA; Pieterman H; van Buuren HR; Laméris JS
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):659-64. PubMed ID: 8668239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts.
    Maleux G; Verslype C; Heye S; Wilms G; Marchal G; Nevens F
    AJR Am J Roentgenol; 2007 Mar; 188(3):659-64. PubMed ID: 17312051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy.
    Hassoun Z; Deschênes M; Lafortune M; Dufresne MP; Perreault P; Lepanto L; Gianfelice D; Bui B; Pomier-Layrargues G
    Am J Gastroenterol; 2001 Apr; 96(4):1205-9. PubMed ID: 11316171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
    Campos S; Gomes D; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.